Evaluation of the Effect of a Dietary Supplement Based on EGCG, Vitamin B12, Hyaluronic Acid, and Folic Acid on the Maintenance of Physiological Balance and the Natural Defenses of the Male Genital System in Subjects Exposed to HPV Infection.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

This is a randomized pilot interventional study aimed at evaluating the effect of a dietary supplement containing EGCG, vitamin B12, hyaluronic acid, and folic acid on the maintenance of physiological balance and natural defenses of the male genital tract in subjects exposed to HPV infection and seeking care for infertility at natural procreation centers. The study includes 48 couples (96 participants) recruited at the International Scientific Institute "Paolo VI" of the A. Gemelli Policlinico, randomly assigned to two groups: 24 couples in which both partners receive one oral tablet per day of the supplement for 6 months, and 24 control couples receiving no supplementation. In addition to the primary objective, secondary outcomes assess potential support of sperm parameters, reproductive well-being of the couples, maintenance of genital mucosal physiological balance with possible reduction of HPV transmission risk to female partners, and support of physiological balance in the presence of co-infections or alterations of the genital microbiota.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Signed informed consent

Couple seeking pregnancy

Male partner aged 25-65 years

HPV DNA test indicating active HPV infection in the male partner

Disqualifiers

Concomitant diseases causing immunosuppression

Treatment with immunomodulatory therapies

Use of EGCG or other green tea extracts

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pervistop

    Dietary supplement

    combination of EGCG, vitamin B12, hyaluronic acid, and folic acid.

Treatment groups

96 Participants
are divided into 2 treatment groups
Group A: Patients taking PervistopExperimental treatment 1 intervention
Group B: Patients NO taking PervistopNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

The aim of the study is to evaluate the effect of a combination of EGCG, vitamin B12, hyaluronic acid, and folic acid on the maintenance of physiological balance and natural defense mechanisms of the male genital tract in subjects who, due to infertility

The aim is to ensure continued HPV test negativity in the male partner throughout the six-month course of Pervistop therapy. The presence of the viral genotype will be determined by urethral swab sampling, followed by gene amplification using polymerase chain reaction (PCR) methodology.

Time frame
From enrollment to the end of treatment at 6 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: